Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - rufinamide, quantity: 400 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; maize starch; hypromellose; lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; macrogol 8000; titanium dioxide; purified talc; iron oxide red - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older

Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - rufinamide, quantity: 200 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; maize starch; hypromellose; lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; macrogol 8000; titanium dioxide; purified talc; iron oxide red - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older

Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - rufinamide, quantity: 100 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; maize starch; hypromellose; lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; macrogol 8000; titanium dioxide; purified talc; iron oxide red - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older

Israel - English - Ministry of Health

eisai israel ltd., israel - rufinamide - film coated tablets - rufinamide 200 mg - rufinamide - rufinamide - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 1 year of age and older.

Israel - English - Ministry of Health

eisai israel ltd., israel - rufinamide - film coated tablets - rufinamide 400 mg - rufinamide - rufinamide - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 1 year of age and older.

Israel - English - Ministry of Health

eisai israel ltd., israel - rufinamide - film coated tablets - rufinamide 100 mg - rufinamide - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 1 year of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

eisai new zealand limited - rufinamide 100mg - film coated tablet - 100 mg - active: rufinamide 100mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 00f44042 sodium laurilsulfate - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

eisai new zealand limited - rufinamide 200mg - film coated tablet - 200 mg - active: rufinamide 200mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 00f44042 sodium laurilsulfate - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

eisai new zealand limited - rufinamide 400mg - film coated tablet - 400 mg - active: rufinamide 400mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 00f44042 sodium laurilsulfate - inovelon is indicated as adjunctive therapy in the treatment of seizures associated with lennox gastaut syndrome in patients 4 years of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam maleate 10.2mg equivalent to 7.5 mg midazolam;   - tablet - 7.5 mg - active: midazolam maleate 10.2mg equivalent to 7.5 mg midazolam   excipient: hypromellose lactose magnesium stearate microcrystalline cellulose purified talc starch titanium dioxide - short-term treatment of insomnia. benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.